Articles by Amy Ritter, PhD - BioPharm International



Articles by Amy Ritter, PhD

USP Announces Proposed Standard for Supply-Chain Integrity

Jan 17, 2012

The US Pharmacopeia (USP) announced in a press release a draft standard contained in the proposed USP General Chapter <1083> Good Distribution Practices?Supply Chain Integrity.

NIH Establishes National Center for Advancing Translational Sciences

Jan 10, 2012

The National Institutes of Health (NIH) announced in a press release the establishment of the National Center for Advancing Translational Sciences (NCATS), a center dedicated to the translation of scientific discoveries into new drugs, diagnostics, and devices.

AstraZeneca to Expand Presence in China

Dec 20, 2011

AstraZeneca entered into an agreement to acquire Guangdong BeiKang Pharmaceutical, a privately owned generic-drug manufacturing company based in Guangdong province, China, for an undisclosed amount. Guangdong BeiKang Pharmaceutical?s portfolio includes injectable medicines used to treat infections. Upon completion of the acquisition, AstraZeneca will be responsible for the manufacture and commercialization of these medicines. The deal is contingent upon approval from the Ministry of Commerce in China and is expected to close in the first quarter of 2012.

FDA Announces Public Meeting to Discuss Biosimilar User Fees

Dec 13, 2011

On Dec. 6, 2011, FDA announced that a public meeting will be held on Dec. 16, 2011 to discuss recommendations for a user-fee program for biosimilar biological products for fiscal years 2013?2017.

Merck Resolves Claims Related to Vioxx for $950 Million

Dec 6, 2011

The justice department announced that the US pharmaceutical company Merck & Co. has agreed to pay $950 million to resolve criminal charges and civil claims related to its promotion and marketing of the painkiller Vioxx.

The Employment Outlook Brightens

Readers react to the economic turmoil of the past year and look longingly forward to 2012.
Dec 1, 2011

Readers react to the economic turmoil of the past year and look longingly forward to 2012.

Alliance Between Pharma and Nonprofits to Speed Development of Tuberculosis Therapies

Nov 22, 2011

AstraZeneca, Bayer, Sanofi, Tibotec, TB Alliance, and the World Health Organization agreed to share information on tuberculosis (TB) compounds within their respective drug pipelines, according to the Critical Path to TB Drug Regimens (CPTR). The purpose of the agreement is to promote information sharing around scientific and clinical studies so that partners can identify opportunities to test compounds in combination. Under the agreement, if two or more organizations choose to work together to further develop a regimen, they will enter into a separate arrangement that defines the rights and responsibilities of each party

President Obama Issues Executive Order to Reduce Drug Shortages

Nov 8, 2011

In response to the increase in drug shortages over the past three years, President Obama issued an executive order on Oct. 31, 2011 that directs FDA to take the following steps to prevent and reduce drug shortages

Merck, Sharpe, and Dohme Announces New Investments in Singapore

Nov 1, 2011

Merck, Sharpe, and Dohme (MSD) and Singapore?s Economic Development Board jointly announced plans for significant investments by MSD to improve its existing manufacturing facilities in Singapore, as well as for new manufacturing, marketing, and research activities.



Click here